Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR projections for investors in 2025. See more.
The spike in demand for the many reagents required for such work has been unprecedented, says Edvinas Paliulis, product manager for molecular biology at Thermo Fisher Scientific in Vilnius ...
buffer conditions and reagent concentration—the company can custom-formulate its products to meet varying process-development requirements (Fig. 1). Furthermore, Thermo Fisher Scientific takes ...
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis ...
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Thursday, January 30th. Analysts expect the company to announce ...
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue ...